Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
akathisia
amyotrophic lateral sclerosis, guamian type of
anti basal ganglia antibodies
autoantibodies
chest pain
cogwheel pursuit movements
convergence, impaired
drug induced neurologic disorders
dyspnea
dystonia
electronystagmography, abnormal
encephalitis
encephalitis lethargica
encephalitis, viral
encephalitis, western equine
epidemiology of neurology
eye movement, disorders of
gaze palsy, vertical
Hallervorden Spatz disease
herpes virus infection
hypometric saccades
Jakob-Creutzfeldt disease
L-dopa, drug interactions with and side effects of
lead poisoning
mongolism
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MRI
MRI, abnormal
MRI, disappearing lesion on
myoclonus
neurofibrillary degeneration
neuroleptic
neuronal ceroid-lipofuscinosis
oculogyric crisis
ophthalmoplegia
Parkinson disease
Parkinson disease, postencephalitic
Parkinson disease, transient
Parkinsonism syndrome
phenothiazine
phenothiazine, dyskinesia associated with
pleocytosis of cerebrospinal fluid
poliomyelitis
psychosis
pupil, abnormality in neurologic disorders
pursuit eye movements, abnormal
pyramidal tract dysfunction
reserpine and reserpine like drugs
reserpine treatment in movement disorder
respirations in CNS disease
respiratory dyskinesias
respiratory tract infection
review article
sleeping sickness
somnolence
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
substantia nigra
tardive dyskinesia
tuberous sclerosis
viral infection
viral infection, CNS
Showing articles 350 to 400 of 1533 << Previous Next >>

Rasagiline as an Adjunct to Levodopa in Patients With Parkinsons Disease and Motor Fluctuations (LARGO, Lasting Effect in Adjunct Therapy With Rasagiline Given Once Daily, Study)
Lancet 365:947-954, 914, Rascol,O., et al, 2005

Pallidal vs Subthalamic Nucleus Deep Brain Stimulation in Parkinson Disease
Arch Neurol 62:554-560,533, Anderson,V.C.,et al, 2005

Pallidal Stimulation Improves Pantothenate Kinase-Associated Neurodegeneration
Ann Neurol 57:738-741,613, Castelnau,P.,et al, 2005

Tourettes Syndrome and Deep Brain Stimulation
JNNP 76:992-995, Houeto,J.L.,et al, 2005

Donepezil for Dementia in Parkinsons Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study
JNNP 76:934-939,903, Ravina,B.,et al, 2005

Short-Term Paroxetine Treatment Does Not Alter the Motor Response to Levodopa in PD
Neurol 64:1797-1798, Chung,K.A.,et al, 2005

Spontaneous CSF Leak Treated with Percutaneous CT-Guided Fibrin Glue
Neurol 64:1818-1819, Gladstone,J.P.,et al, 2005

[99mTc]TRODAT-1 SPECT Imaging Correlates with Odor Identification in Early Parkinson Disease
Neurol 64:1716-1720, Siderowf,A.,et al, 2005

The role of radiotracer imaging in Parkinson disease
Neurol 64:208-215, Ravina, B., et al, 2005

Amorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease
Neurol 64:392-393, Pot, C., et al, 2005

Searching for a Relationship Between Manganese and Welding and Parkinsons Disease
Neurol 64:2021-2028, 2001, Jankovic,J., 2005

Neurologic Manifestations in Welders with Pallidal MRI T1 Hyperintensity
Neurol 64:2033-2039,2001, Josephs,K.A.,et al, 2005

New and Reliable MRI Diagnosis for Progressive Supranuclear Palsy
Neurol 64:2050-2055, Oba,H.,et al, 2005

Pleuropulmonary Fibrosis After Long-term Treatment With the Dopamine Agonist Pergolide for Parkinson Disease
Arch Neurol 62:1290-1295, Tintner,R.,et al, 2005

Sudden Uncontrollable Somnolence and Medication Use in Parkinson Disease
Arch Neurol 62:1242-1248, Avorn,J.,et al, 2005

Camptocormia
Neurol 65:355-359, Azher,S.N. &Jankovic,J., 2005

Initial Diagnoses Given to Persons with the Fragile X Associated Tremor/Ataxia Syndrome (FXTAS)
Neurol 65:299-301, Hall,D.A.,et al, 2005

The Role of Levodopa in the Management of Dementia With Lewy Bodies
JNNP 76:1200-1203, Moloy,S.,et al, 2005

Cluster Headache:Pathogenesis,Diagnosis, and Management
Lancet 366:843-855, May,A., 2005

Diagnosis and Initial Management of Parkinsons Disease
NEJM 353:1021-1027, Nutt,J.G.&Wooten,G.F., 2005

Science and Ethics of Sham Surgery, A Survey of Parkinson Disease Clinical Researchers
Arch Neurol 62:1357-1360,1343, Kim,S.Y.H.,et al, 2005

Neurologic Spectrum of Chronic Liver Failure and Basal Ganglia T1 Hyperintensity on Magnetic Resonance Imaging, Probably Manganese Neurotoxicity
Arch Neurol 62:1385-1390, Klos,K.J.,et al, 2005

Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Arch Neurol 62:1377-1381, Dodd,M.L.,et al, 2005

Neuropathology of Dementia in Parkinsons Disease: A Prospective, Community-Based Study
Ann Neurol 58:773-776,663, Aarsland,D.,et al, 2005

Cabergoline-Related Severe Restrictive Mitral Regurgitation
NEJM 353:1974-1975, Rosen,C.J., 2005

Occupation and Parkinsonism in Three Movement Disorders Clinics
Neurol 65:1430-1435, Goldman,S.M.,et al, 2005

Excessive Daytime Sleepiness and Subsequent Development of Parkinson Disease
Neurol 65:1442-1446, Abbott,R.D.,et al, 2005

Levodopa Addiction in Idiopathic Parkinson Disease
Neurol 65:1508, Borek,L.L &Friedman,J.H., 2005

Modafinil for Daytime Somnolence in Parkinsons Disease: Double Blind, Placebo Controlled Parallel Trial
JNNP 76:1636-1639, Ondo,W.G.,et al, 2005

Two Patients With COMT Inhibitor-Induced Hepatic Dysfunction and UGT1A9 Genetic Polymorphism
Neurol 65:1820-1822, Martignoni,E.,et al, 2005

Diagnosis and Management of Dementia with Lewy Bodies
Neurol 65:1863-1872, McKeith,I.G.,et al, 2005

Levodopa and the Progression of Parkinson's Disease
NEJM 351:2498-2508, The Parkinson Study Group, 2004

Rivastigmine for Dementia Associated with Parkinson's Disease
NEJM 351:2509-2518,2547, Emre,M.,et al, 2004

Suicide After Successful Deep Brain Stimulation for Movement Disorders
Neurol 63:2170-2172, Burkhard,P.R.,et al, 2004

Correlation Between Antemortem Magnetic Resonance Imaging Findings and Pathologically Confirmed Corticobasal Degeneration
Arch Neurol 61:1881-1884, Josephs,K.A.,et al, 2004

Parenteral Metoclopramide for Acute Migraine: Meta-Analysis of Randomised Controlled Trials
BMJ 329:1369-1372, Colman,I.,et al, 2004

Effective Cabergoline Treatment in Idiopathic Restless Legs Syndrome
Neurol 63:2272-2279, Stiasny-Kolster,K.,et al, 2004

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Pract Neurology 4:50-55, Razvi,S.S.M. &Muir,K.W., 2004

The Parkinsonian Phenotype of Spinocerebellar Ataxia Type 2
Arch Neurol 61:35-38, Lu,C.,et al, 2004

Penetrance of the Fragile X-Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population
JAMA 291:460-469, Jacquemont,S.,et al, 2004

Neuroprotection in Parkinson Disease, Mysteries, Myths, and Misconceptions
JAMA 291:358-364, Schapira,A.H.V.&Olanow,C.W., 2004

Ophthalmologic Features of Parkinson's Disease
Neurol 62:177-180, Biousse,V.,et al, 2004

Effect of Levodopa Treatment for Parkinsonism in Welders
Neurol 62:730-733, Koller,W.C.,et al, 2004

Ropinirole in Gilles de la Tourette Syndrome
Neurol 62:1626-1627, Anea,M.H.,et al, 2004

Efficacy of Pergolide in Treatment of Restless Legs Syndrome
Neurol 62:1391-1397, Trenkwalder,C.,et al, 2004

Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004

Treatment of Parkinson's Disease with Pergolide and Relation to Restrictive Valvular Heart Disease
Lancet 363:1179-1183, Van Camp,G.,et al, 2004

Transient Insomnia Induced by High-Frequency Deep Brain Stimulation in Parkinson Disease
Neurol 62:1232-1233, Monaca,C.,et al, 2004

Parkinson's Disease
Lancet 363:1783-1793, Samii,A.,et al, 2004

Basal Ganglia Hyperperfusion in a Patient with Systemic Lupus Erythematosus-Related Parkinsonism
Neurol 63:395-396, Lee,P.H.,et al, 2004



Showing articles 350 to 400 of 1533 << Previous Next >>